Skip to content
  • Wednesday, 15 April 2026
  • 10:17 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly’s Triple Agonist Retatrutide Achieves Remarkable 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes
Laboratory Automation & Robotics

Eli Lilly’s Triple Agonist Retatrutide Achieves Remarkable 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes

Lana Keisha Mar 27, 2026 0

Eli Lilly and Company has announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…

Read More
First Blueprint of Human Skeletal Development Reveals Cellular Origins of Arthritis and Congenital Bone ConditionsCoordinated molecular and physiological adaptations enable activity at subfreezing temperature in the snow fly Chionea alexandrianaBeyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity marketAbacus AI’s ChatLLM Emerges as a Unified AI Solution Amidst Fragmented Tool Landscape
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic InterruptionThe Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line DevelopmentImmuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure ThroughputMental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption
Dwi Wanna Apr 15, 2026
Biotech & Genetic Research
The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development
Jia Lissa Apr 15, 2026
Laboratory Automation & Robotics
Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput
Lana Keisha Apr 15, 2026
Neuroscience & Brain Research
Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
Rifan Muazin Apr 15, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ